Prevalence, incidence, and medications of narcolepsy in Japan: a descriptive observational study using a health insurance claims database.

ABSTRACT: The objectives of this study were to describe prevalence, incidence, and medications among patients who were diagnosed with narcolepsy in Japan using a claims database. Patients diagnosed with narcolepsy were identified from January 2010 to December 2019 using an employment-based health insurance claims database compiled by JMDC Inc. The prevalence and incidence of narcolepsy were estimated annually in the overall population and by age and sex among employees and their dependents aged < 75 years. Medications, examined for each quarter in the overall population, were modafinil, methylphenidate, pemoline, tricyclic antidepressants, selective serotonin reuptake inhibitors, and serotonin-norepinephrine reuptake inhibitors. We identified 1539 patients with narcolepsy. The overall annual prevale

SUBMITTER: Imanishi A 

PROVIDER: S-EPMC10899966 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature